Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
The AST commends Dr. Deepali Kumar and Dr. Atul Humar for their recently released article in the New England Journal of Medicine, "A Randomized Trial of Third Dose mRNA-1273 Vaccine in Transplant Recipients." We hope this information will be impactful as both the transplant community and the Federal government consider data-driven next steps related to the value of a third vaccination to enhance protection from severe COVID-19 infection among immunocompromised individuals. Congratulations to Drs. Kumar, Humar and their colleagues on this research effort. The AST will be updating its COVID-19 resources accordingly pending the release of any FDA updates regarding the potential value of third vaccines.